Background The ideal timing for melanoma treatment, predominantly surgery, remains
undetermined. Patient concern for receiving immediate treatment often exceeds surgeon or …

Background The effect of treatment delays on melanoma outcomes remains unclear.
Objective To assess the impact of surgical treatment delays on melanoma-specific mortality …

Background The surgical management of primary cutaneous malignant melanoma usually
involves an excision biopsy of the suspected lesion followed by wide local excision. No …

Importance Timely receipt of treatment for cancer is an important aspect of health care
quality. It is unknown how delays of surgery for melanoma vary by insurance type. Objective …

Given recent developments in the treatment of metastatic melanoma, early detection of
disease recurrence is crucial. The aim of this single-centre retrospective cohort study was to …

Background While curable at early stages, few treatment options exist for advanced
melanoma. Currently, no consensus exists regarding the optimal surveillance strategy for …

Background Longer time from diagnosis to definitive surgery (TTDS) is associated with
increased melanoma-specific mortality. Although black patients present with later-stage …

Purpose Pathologic stage II melanoma patients have variable outcomes when divided by
substage. We hypothesized that an understanding of the patterns of initial relapse by …

Background After appropriate initial therapy for patients with stage II-III melanoma, there is
no consensus regarding surveillance. Thus, follow-up is highly variable among institutions …

Purpose Stage III melanoma is associated with a high risk of relapse and mortality.
Nevertheless, follow-up guidelines have largely been empirical rather than evidence-based …